Two Onc Docs cover image

Bone Modifying Agents

Two Onc Docs

00:00

Introduction

Exploring the role of Bisphosphonates and Denosumab in reducing skeletal related events in cancer patients with bone metastases, emphasizing their importance for healthcare professionals in oncology and internal medicine.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app